ADHD and ASD polygenic risk scores correlate with antipsychotic responsiveness in schizophrenia postmortem brains
This postmortem brain study included 24 patients with schizophrenia and 48 controls; 19 patients with schizophrenia had antemortem clinical information. The study examined polygenic risk scores (PRSs) for ADHD and ASD as exposures and used controls and high vs low ADHD-PRS groups as comparators. The primary outcome was an antipsychotic responsiveness score (ARS).
For the ARS of positive symptoms (ARS-PS), the results showed a suggestive negative correlation with ADHD-PRS and a positive correlation with ASD-PRS. No correlation was observed for the ARS of general psychopathology or negative symptoms. Gene expression analysis identified 1,773 differentially expressed genes (DEGs), including neuropsychiatric disorder-related genes such as CHRNB2.
Safety and tolerability were not reported. Key limitations include that the associations did not survive multiple testing correction and the sample size was limited. These are exploratory findings with weak evidence strength. Clinicians should interpret these results with caution, as they do not support causal inferences or changes to practice.